Big banks kick off earnings season Friday, and many analysts expect robust results after a post-election stock-trading frenzy that may have provided stronger revenue.
Lined up for tomorrow are Bank of America Corp(NYSE: BAC), JPMorgan Chase & Co. (NYSE: JPM), and Wells Fargo & Co (NYSE: WFC), and there’s plenty of enthusiasm going into the results. The financial sector overall appears to have been a big benefactor of what traders are calling the “Trump rally,” a market surge that began almost immediately after the November presidential elections. BAC shares have swelled some 35% since Nov. 8 to reach an eight-year high, while JPM shares are higher by nearly 29% after reaching record peaks. WFC is up by 20% after tapping an 18-month high.
Analysts expect these banks (as well as Morgan Stanley (NYSE: MS), Goldman Sachs Group Inc (NYSE: GS), and Citigroup Inc (NYSE: C), which are expected to report next week) to turn in robust results thanks to stronger trading revenues and higher yields on Treasury notes. They could also be bolstered by a handful of products like credit cards, and student and consumer loans. Trading revenue, particularly in fixed income, currency and commodities, had been a sore spot for banks up until about Q2. That started to stabilize last year and apparently was buttressed further with the post-election trading extravaganza.
Best Bank Stocks To Invest In 2018: Cyclacel Pharmaceuticals Inc.(CYCC)
- [By Alex McGuire]
These are the 10 best penny stocks that have seen the biggest returns over the last week (March 7 – March 14)…
Penny StockCurrent PriceWeekly Gain (March 7 – March 14)Ocera Therapeutics Inc. (Nasdaq: OCRX)$1.47+147.1%Internap Corp. (Nasdaq: INAP)$3.28+41.4%Soligenix Inc. (Nasdaq: SNGX)$2.94+40%Navios Maritime Partners LP (NYSE: NMM)$2.63+37%QuickLogic Corp. (Nasdaq: QUIK)$2.14+30.5%Adamis Pharmaceuticals Corp. (Nasdaq: ADMP)$4.60+22.7EXCO Resources Inc. (NYSE: XCO)$0.65+20.5%Cyclacel Pharmaceuticals Inc. (Nasdaq: CYCC)$4.38+20.3%Hebron Technology Co. Ltd. (Nasdaq: HEBT)$3.99+19.1%Curis Inc. (Nasdaq: CRIS)$2.85+18.4%
As a reminder, this is only a tracking metric of penny stocks trading on SEC-regulated exchanges like the Nasdaq and NYSE. Although these top penny stocks are safer than those trading on the pink sheets, we don’t recommend buying any of them without the proper amount of financial research.
- [By Alex McGuire]
As a service to our readers, the following list provides the 10 top pharmaceutical stocks to watch this month (May 2017), including the biggest gainers from April…
Pharmaceutical Stock Current Share Price April 2017 Gain
Cleveland BioLabs Inc. (Nasdaq: CBLI) $3.62 +120.6%
Nexvet Biopharma Plc. (Nasdaq: NVET) $6.61 +69.7%
Motif Bio Plc. (Nasdaq ADR: MTFB) $10.10 +68.2%
Axovant Sciences Ltd. (NYSE: AXON) $24.43 +62.3%
Cyclacel Pharmaceuticals Inc. (Nasdaq: CYCC) $5.49 +46.7%
Conatus Pharmaceuticals Inc. (Nasdaq: CNAT) $8.67 +44.9%
Akebia Therapeutics Inc. (Nasdaq: AKBA) $13.07 +43.3%
Akorn Inc. (Nasdaq: AKRX) $33.28 +38.9%
Rockwell Medical Inc. (Nasdaq: RMTI) $8.78 +37.4%
Akari Therapeutics Plc. (Nasdaq ADR: AKTX) $15.02 +35.4%
The best-performing pharma stock of the month – Cleveland BioLabs Inc. – surged 120.6% to $3.53 a share by April 28. That crushed both the Nasdaq Biotech Index’s 1.5% gain and the Dow Jones’ 1.3% rise over the same period.
Best Bank Stocks To Invest In 2018: E*TRADE Financial Corporation(ETFC)
- [By Jon C. Ogg]
E*Trade Financial Corp. (NASDAQ: ETFC) was up another 1.6% at $32.97. Ithas a total market cap of $9 billion, and over the past five trading days the stock has gained 17%. Shares of Morgan Stanley (NYSE: MS) were last seen at $39.09, up 17% in the past fivetrading days. The market cap is$74.7 billion.
- [By Chris Neiger]
This article will walk your through all the steps for setting up an individual E*TRADE (NASDAQ:ETFC) brokerage account, which should only take about five to 10 minutes to complete. If you want to compare offers from other brokers, or view their features, check out ourbroker comparison page.
- [By Dan Caplinger]
Meanwhile, E*Trade (NASDAQ:ETFC) decided to split the difference. Effective March 13, E*Trade’s commission structure will get split in two. Base rate customers will see their commissions fall from $9.99 to $6.95 per trade, matching TD Ameritrade. However, E*Trade created a new structure for active traders, defined as those who execute 30 or more trades every three months. For those customers, E*Trade will have $4.95 per trade commissions, and options charges will fall by a third, to $0.50 per contract. CEO Karl Roessner said that although “an exceptional customer experience is far more important to traders and investors than price, with our new commission structure, we are able to reward our most active equity and derivative traders and investors.”
- [By WWW.THESTREET.COM]
Franklin Resources (BEN) : “I’d rather see you in Morgan Stanley (MS) or E*TRADE Financial (ETFC) .”
Kinder Morgan (KMI) : “They are OK now, but there are better ones.”
Best Bank Stocks To Invest In 2018: Finjan Holdings, Inc.(FNJN)
- [By Taylor Cox]
Finjan Holdings, Inc (NASDAQ: FNJN)
Danaher Corporation (NYSE: DHR)
Delta Air Lines, Inc (NYSE: DAL)
Deckers Outdoor Corporation (NYSE: DECK) annual shareholder meeting, to vote on Marcato Capital board nominees